Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

RADIOACTIVE RADIATION INJURY: ITS ORIGIN, SYMPTOMATOLOGY, PROPHYLAXIS, AND THERAPY (in German)

Journal Article · · Pharmaceutica Acta Helvetiae (Switzerland)
OSTI ID:4736183
Drugs and techniques employed in the prevention and treatment of radiation injury are described, and there is a discussion on: the nature of ionizing radiations, both of the primary and secondary type; primary and secondary reactions of radiations with biological materials and systems; the interaction of radiations with sulfhydryl groups; the means by which human radiation injury may be incurred, from various internal and external sources; symptoms, pathology, phases, and dose-relations of radiation sickness in humans; radiosensitivity of various human tissues; and genetic effects of radiation. In addition to the radioprotective thiol compounds, such as cysteamine, cysteine, and BETA -aminoethylthiuronium, some protection is afforded by a variety of substances, for which the mechanism of protection is unknown, including: sympathomimetic phenylalkylamines, such as amphetamine, especially in combination with thiol compounds; phosphate esters with anticholinesterase activity, such as octaethyltetramide pyrophosphate; serotonin; Na chlorophyll; and sitosterol. Drugs suitable for treatment of various aspects of radiation sickness in man are also discussed, including phenothiazines and barbiturates for psychic disturbances, plasma expanders for shock, antihistamines for stress reactions, antibiotics for infections, liver protectants, parenteral nutrients, antihemorrhagic agents, and hematopoietic cofactors and vitamins. Use of various chelating agents for removal of ingested radionuclides is also considered, and applications of ethylenediaminetetraacetate, diaminodiethyl ether pentaacetate, dimercaptopropanol (BAL), and Na and Zr citrate are cited. (H.H.D.)
Research Organization:
Kantonsapotheke, Zurich
NSA Number:
NSA-17-017932
OSTI ID:
4736183
Journal Information:
Pharmaceutica Acta Helvetiae (Switzerland), Journal Name: Pharmaceutica Acta Helvetiae (Switzerland) Vol. Vol: 38; ISSN PAHEA
Country of Publication:
Country unknown/Code not available
Language:
German